Vyvanse increases dopamine and norepinephrine levels, helping to control the impulsivity often linked with binge eating
These occur because the body is adjusting to a new level of GIP and GLP-1 hormones
To succeed, companies should master the complexities of the OOP model (Figure 6) by building patient insights, partnering with digital and retail health providers, and assessing DTC models for broader use
Speaking in Chicago at ASCO, Dr Mitchell Lazar, the director of the institute for diabetes, obesity and metabolism at the University of Pennsylvania School of Medicine, said: GLP-1 based therapies are highly effective at producing weight loss, and thus one of the fundamental mechanisms by which they improve cancer outcomes is via the impressive weight loss that they produce
Every program reflects what he's learned clinically and personally about what it actually takes to change your health long-term